You are here: DOCET > Distance Learning Projects > Optometric Quarterly > OQ61 > Lucentis® for wet AMD

Lucentis® for wet AMD





Listen/download here:   Stream OQ 61 Part 1 - download
 
Adnan Tufail of Moorfields talks to Hugh Breakspear about the latest drug in this fast-developing area.
 
  

Adnan Tufail

Adnan Tufail

Hugh Breakspear

Hugh Breakspear

References

 

Rosenfeld PJ et al for the MARINA Study group. Ranibizumab for neovascular age-related

macular degeneration: 2-year results of the MARINA study. N Engl J Med 2006; 355:1419-31.

http://content.nejm.org/cgi/content/abstract/355/14/1419

 
Brown DM et al. Comparison of ranibizumab and verteporfin photodynamic therapy for neovascular
age-related macular degeneration: 1-year results of the ANCHOR study. N Engl J Med 2006; 355:1432-44.
http://content.nejm.org/cgi/content/abstract/355/14/1432


See also: